Ovid Therapeutics, Inc. (OVID)
2.80
-0.13
(-4.44%)
USD |
NASDAQ |
Aug 28, 16:00
2.77
-0.03
(-1.07%)
After-Hours: 06:06
Ovid Therapeutics Debt to Equity Ratio : 0.0606 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0606 |
| March 31, 2026 | 0.0659 |
| December 31, 2025 | 0.1027 |
| September 30, 2025 | 0.3079 |
| June 30, 2025 | 0.2527 |
| March 31, 2025 | 0.2434 |
| December 31, 2024 | 0.2163 |
| September 30, 2024 | 0.2103 |
| June 30, 2024 | 0.184 |
| March 31, 2024 | 0.5838 |
| December 31, 2023 | 0.524 |
| September 30, 2023 | 0.1609 |
| June 30, 2023 | 0.1476 |
| March 31, 2023 | 0.1364 |
| December 31, 2022 | 0.125 |
| September 30, 2022 | 0.1144 |
| June 30, 2022 | 0.1049 |
| March 31, 2022 | 0.0962 |
| December 31, 2021 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 231.97M |
| Total Liabilities (Quarterly) | 22.08M |
| Shareholders Equity (Quarterly) | 209.89M |
| Current Ratio | 12.39 |
| Net Debt Paydown Yield | 0.07% |